Genmab — Februar 2018

[StockBull]

Kan han gentage

[StockBull]

Hvis markedet ellers arter sig de kommende maaneder. Beklager min iPad driller.

[E_L]

it is not unusual lately for price to drop in anticipation of warrant exercise

[Mcjean]

If Genmab have any mercy with stockholders they wait until friday after close:-)

[E_L]

if i look at this https://clinicaltrials.gov/archive/NCT02792218/2018_02_26/changes on the ASCLEPIOS I trial (Ofa/MS), wouldn't it be fair to say that Novartis is starting to get an idea of efficacy already?

[E_L]

they can't Mcjean, dates are set long time ago

[E_L]

by the way Celgene had a refusal by FDA on Ozanimod for MS, different sort of drug as Ofa, but still. https://www.businesswire.com/news/home/20180227006637/en/

[Bulder]

Do you know why all hospitals are called "Novartis Investigative Site". Haven't seen that before.

[Investor13]

Nogle der ved hvornår medarbejderne smider deres warrants i mark
kedet?

[Investor13]

markedet skulle der stå

[E_L]

No Bulder, don't know why they do that. If I am just guessing it might be a legal issue mentioning Novartis instead of the hospital name, an issue with rights or liability?

[Repsac]

HSBC kursmål er sikkert i USD.

[Parasitism]

Det ville næsten give mere mening

[peter12]

En ældre blogpost om Ofa http://multiple-sclerosis-research.blogspot.com/search?q=ofatumumab

[anncba]

Eller også er det kursmålet, når den er blevet splittet (O:

[pauly]

Anon samler op. Der ser ikke ud til det kursmål har særlig efftekt

[Teller]

Det er vel også kun de færreste der mener Genmab skal ned i kurs 1000, selv
på kort sigt.

[mobbyduck1]

det er kun OHW,

[mobbyduck1]

og AQR selvfølgelig

[OHW]

..jeg mener det ikke men vil heller ikke udelukke det. Jeg vil sige, at det ikke er ret sandsynligt vil skal i 1000. Vi får se..